Table 2. Imidazole inhibition of JH III production by CA in vitro and by recombinant CYP15A1.
| Imidazole | IC50 CA in vitro, μM* | IC50 CYP15A1, μM† | |
|---|---|---|---|
| TH27 |
|
0.036 | 0.025 ± 0.014 |
| KK96 | 0.77 | 0.2 ± 0.09 | |
| KK71 | 48 | 60 ± 5 |
Concentration for 50% inhibition of JH III biosynthesis by CA in vitro. The IC50 values were taken from ref. 12 (KK96 and TH27) and ref. 20 (KK71).
Concentration for 50% inhibition of methyl (2E,6E)-farnesoate epoxidation by recombinant CYP15A1 in a reconstituted system (mean ± SD, n = 3). Epoxidation of methyl farnesoate by E. coli membranes containing recombinant CYP15A1 was measured as described in Materials and Methods.
